|Articles|May 15, 2002
A versatile product: FDA approves botulinum toxin for glabellar lines
Irvine, CA-The FDA has approved the use of botulinum toxin type A (Botox, Allergan, Irvine, CA) for temporary improvement in the appearance of moderate to severe glabellar lines in adult men and women 65 or younger.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
STAAR Surgical terminates proposed acquisition by Alcon
2
Innovations in glaucoma poised for breakthrough in 2026 (and what might hold them back)
3
Rates of retinal layer thinning predict visual field progression in glaucoma
4
FDA grants Breakthrough Therapy Designation to Oculis’ privosegtor for optic neuritis
5








































